About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aura Biosciences, Inc. - Common Stock (NQ:AURA)

7.270 +0.540 (+8.02%)
Streaming Delayed Price Updated: 11:52 AM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 296,637
Open 6.770
Bid (Size) 7.270 (300)
Ask (Size) 7.280 (200)
Prev. Close 6.730
Today's Range 6.580 - 7.460
52wk Range 4.730 - 9.535
Shares Outstanding 38,197,098
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances ↗
Aura Biosciences (NASDAQ:AURA) is shifting its focus toward regulatory preparation and commercialization planning as enrollment in its registrational CoMpass study of bel-sar in early choroidal... 
Via MarketBeat
News headline image
Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data ↗
Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the... 
Via MarketBeat

Performance

YTD
+37.2%
+37.2%
1 Month
+1.1%
+1.1%
3 Month
+8.5%
+8.5%
6 Month
+33.4%
+33.4%
1 Year
+16.1%
+16.1%

More News

Read More
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
Topics Stocks
News headline image
Recap: Aura Biosciences Q4 Earnings ↗
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Aura Biosciences Posts Q2 Cash Surge ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
4 Artificial Intelligence Stocks (That Aren't Nvidia) You Can Buy and Hold for the Next Decade ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert ↗
Via Benzinga
Topics Supply Chain World Trade
News headline image
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
3 Small-Cap Stocks Ready to Deliver Significant Growth
Via MarketBeat
Topics Economy
News headline image
Aura Biosciences Touts Promising Data From Eye Cancer Candidate ↗
Via Benzinga
News headline image
AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024 ↗
Via InvestorPlace
News headline image
AURA Stock Earnings: Aura Biosciences Beats EPS for Q1 2024 ↗
Via InvestorPlace
News headline image
AURA Stock Earnings: Aura Biosciences Beats EPS for Q4 2023 ↗
Via InvestorPlace
News headline image
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
From Aura Biosciences, Inc.
Via Business Wire
News headline image
Aura Biosciences to Participate in Upcoming Investor Conferences
From Aura Biosciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma
From Aura Biosciences Inc.
Via Business Wire
News headline image
Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying ↗
Via Benzinga
News headline image
Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
From Aura Biosciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Aura Biosciences, Inc. - Common Stock publicly traded?
Yes, Aura Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Aura Biosciences, Inc. - Common Stock trade on?
Aura Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aura Biosciences, Inc. - Common Stock?
The ticker symbol for Aura Biosciences, Inc. - Common Stock is AURA on the Nasdaq Stock Market
What is the current price of Aura Biosciences, Inc. - Common Stock?
The current price of Aura Biosciences, Inc. - Common Stock is 7.270
When was Aura Biosciences, Inc. - Common Stock last traded?
The last trade of Aura Biosciences, Inc. - Common Stock was at 07/02/26 11:52 AM ET
What is the market capitalization of Aura Biosciences, Inc. - Common Stock?
The market capitalization of Aura Biosciences, Inc. - Common Stock is 277.69M
How many shares of Aura Biosciences, Inc. - Common Stock are outstanding?
Aura Biosciences, Inc. - Common Stock has 278M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.